Fishmeal producers adopted ethoxyquin to reduce fires during storage and shipping, but health and environmental concerns led to bans in the EU and several other countries. Some producers are shifting to alternatives such as BHA, which has also drawn carcinogenicity concerns and is under reassessment by U.S. regulators; detected ethoxyquin levels in imported seafood cited in the article were below the FDA safety limit.
Restrictions or reassessment of antioxidants could raise handling and compliance costs for fishmeal producers and affect the choice of additives, but the article reports no direct change in fishmeal supply or prices.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.